The past few weeks have been quite difficult for shareholders in Therapeutic Solutions International Inc (OTCMKTS:TSOI) as the stock continued to suffer from a selloff.
Over the course of the past week alone, the stock has declined by a hefty 17% and the losses in the past month now stand at as much as 45%. While the losses made by the stock are considerable it is perhaps also important to note that yesterday the company made a significant announcement and it could be a good idea for investors to perhaps take a closer look at it.
Therapeutic Solutions revealed data and also filed a patent in relation a product that helps in suppressing lung injury and eventual regeneration of lungs. The treatment in question combines JadiCells and T Regulatory cells. It was a major announcement from Therapeutic Solutions and it remains to be seen if it can prove to be a positive trigger for the stock or not.
The Chief Medical Officer of Therapeutic Solutions Dr James Veltmeyer spoke about it as well. He stated that Therapeutic Solutions is always on the lookout for new ways in which it can further improve the efficiency of its different therapies.
TSOI stock was under pressure on Wednesday as the stock fell another 1.60%, extending its monthly fall to 45%. The stock traded 11.47 million shares, compared to its average volume of 14.35 million shares.